Firstly, welcome to the new Kosmos website! What you see

New Post Public Reply Private Reply Replies (0) Message Board
Krisandtilly Krisandtilly #17560
Firstly, welcome to the new Kosmos website! What you see here is the foundations of what we intend to be a much larger building. Traditionally, a TV show or a movie is presented to an audience "complete": fine tuned, polished, marketed, packaged and then boom - a big launch and fingers crossed it has a huge opening. Kosmos is going to be a little bit different. We are inviting you in at the ground level and hope you will enjoy building something with us.

There's nothing wrong with the traditional format of presenting a TV show or web series, but there's no harm in trying something new, is there? The internet presents us with fresh opportunities and possibilities. As Kosmos Citizens, you have the chance to be part of building this show from this modest beginning into something a bit more epic.

We have started with the minimum of resources, producing 5 parts of a scifi mystery thriller. Occasionally, we found ourselves sailing a bit too close to the wind, but we stuck to our task and got through it. Though there is a lot of work to do, the sumit now appears within striking distance.

When we look at big scifi franchises, like Star Trek and Dr Who, we might forget those shows which are now mighty oaks were once tiny, rather vulnerable shoots in the ground, no bigger than a blade of grass. It took many decades for them to grow into what they are now; many years of careful nurturing.

Kosmos is at that vulnerable stage. It's just been born into this world. Not even the first episode has been aired. I mean, you don't even know if it's your thing, right? If this show is to grow beyond a tiny shoot, we need to nurtre it. That's me and you, together. It's very much a challenge. You might even say the odds are against us. But it will be fun trying, won't it?

I've mentioned this before; that the Statue of Liberty would maybe not now be standing if it hadn't been for one of the first successful crowdfunding campaigns. Thousands of New Yorkers chipped in tiny amounts of money to pay for the base on which the statue now stands. The majority of contributions were less than $1. But I think the pride at knowing you had contributed your bit would be same.

There is a theme of liberty in this project. We are creating this, filmmaker and audience together. There is no middle-man/woman to tell us what we can and can't do; what we are allowed to say, or not. Perhaps we have lost something since the captains of industry stood between us and dictated what we should consume.

You see, I like to think this is not just a step into the future, but also a reworking of past success. Think of Shakespeare and how he was not just a playwright. He was an actor who had to perform his plays, eyeball to eyeball with his audience. Actually, in any theatre production there is a connection between the performers and the audience you just don't get in TV or film. So, with this platform we are building here to give you a voice and a part to play, perhaps our Kosmos will have an essence of that.

I wrote Kosmos not while dreaming of red carpets and golden awards. I wrote it while I was thinking of you and how we could make something together; where you're not just "cattle" (as one Hollywood director recently suggested) passively awaiting to be spoonfed the next morsel; where you are actively involved in making this thing a success and, if we succeed, your names will be forever immortalised within it.

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 8

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Boost for Inseego as George Mulhern Joins Board

Updated Category News Views 140

Inseego Welcomes George Mulhern to Its Board of Directors Inseego Corp. (Nasdaq: INSG) is thrilled to announce the appointment of George Mulhern, a distinguished leader in the wireless technology sector, to its Board of Directors. With a profound background in developing and steering wireless tech companies, Mr. Mulhern has most recently held the position of Senior Vice...

Continue Reading
Economic Outlook Raises Concerns of Inflation Under Trump

Updated Category News Views 128

Increased Economic Concerns with Trump's Return Recent findings reveal that economists are increasingly worried about the potential return of former President Donald Trump and its effects on inflation and federal deficits. Survey Findings on Inflation and Economic Policies A survey conducted by a group of economists indicates a majority foresee higher inflation and...

Continue Reading
Join the Class Action Against Rocket Pharmaceuticals Today

Updated Category News Views 134

Join the Class Action Against Rocket Pharmaceuticals Investors are being called to participate in a class action lawsuit concerning Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). This lawsuit is aimed at recovering losses incurred by shareholders due to alleged securities fraud that impacted the company's financial standing during a specified timeframe. Understanding the...

Continue Reading
Nipocalimab Receives Priority Review from U.S. FDA for gMG

Updated Category News Views 297

Nipocalimab Secures U.S. FDA Priority Review Status Johnson & Johnson (NYSE: JNJ) has exciting news regarding its investigational drug, Nipocalimab. The U.S. Food and Drug Administration (FDA) has granted Priority Review designation for Nisocalimab as a treatment for generalized myasthenia gravis (gMG) in patients with specific autoantibodies. This important milestone...

Continue Reading
Navigating the Canadian Multifamily Landscape: Supply and Demand

Updated Category News Views 89

Understanding Canada's Multifamily Market Trends In recent times, the Canadian multifamily housing market has exhibited some intriguing trends, particularly concerning rent growth and vacancy rates. As highlighted in the latest report from Yardi Canada, the market showcases a scenario where rent growth is slowing, while vacancies remain low. This situation reflects the...

Continue Reading